CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 68 filers reported holding CATALYST BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,700 | +37.2% | 67,800 | 0.0% | 0.00% | +50.0% |
Q2 2023 | $23,838 | -28.2% | 67,800 | -57.7% | 0.00% | -33.3% |
Q1 2023 | $33,209 | -85.6% | 160,430 | -63.4% | 0.00% | -80.0% |
Q4 2022 | $231,074 | -82.1% | 438,055 | -82.9% | 0.02% | -81.9% |
Q3 2022 | $1,288,000 | -73.7% | 2,554,735 | -7.3% | 0.08% | -66.3% |
Q2 2022 | $4,906,000 | +207.0% | 2,755,903 | +13.8% | 0.25% | +246.5% |
Q1 2022 | $1,598,000 | -36.7% | 2,420,789 | -12.3% | 0.07% | -20.2% |
Q4 2021 | $2,524,000 | -74.7% | 2,761,660 | +13.5% | 0.09% | -71.7% |
Q3 2021 | $9,996,000 | -8.8% | 2,432,212 | -3.9% | 0.32% | +1.3% |
Q2 2021 | $10,961,000 | -15.1% | 2,531,360 | -1.2% | 0.31% | -17.5% |
Q1 2021 | $12,909,000 | +9.7% | 2,561,334 | +37.3% | 0.38% | +3.3% |
Q4 2020 | $11,770,000 | +50.2% | 1,865,334 | +2.4% | 0.36% | +52.1% |
Q3 2020 | $7,834,000 | -26.7% | 1,821,749 | 0.0% | 0.24% | -25.5% |
Q2 2020 | $10,694,000 | +69.2% | 1,821,749 | +25.9% | 0.32% | +35.9% |
Q1 2020 | $6,322,000 | -13.4% | 1,446,749 | +35.0% | 0.24% | +5.3% |
Q4 2019 | $7,299,000 | +39.9% | 1,071,749 | +0.8% | 0.22% | +16.6% |
Q3 2019 | $5,219,000 | -32.1% | 1,062,843 | +1.9% | 0.19% | -18.6% |
Q2 2019 | $7,686,000 | -1.1% | 1,042,843 | +8.8% | 0.24% | -2.1% |
Q1 2019 | $7,771,000 | +15.2% | 958,243 | +12.0% | 0.24% | +16.3% |
Q4 2018 | $6,748,000 | – | 855,243 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,635,014 | $10,830,000 | 4.93% |
22NW, LP | 1,429,242 | $5,874,000 | 1.75% |
Ghost Tree Capital, LLC | 1,000,000 | $4,110,000 | 1.20% |
Sio Capital Management, LLC | 623,892 | $2,564,000 | 0.82% |
ACUTA CAPITAL PARTNERS, LLC | 365,000 | $1,500,000 | 0.53% |
Nantahala Capital Management | 2,432,212 | $9,996,000 | 0.32% |
Parkman Healthcare Partners LLC | 133,449 | $548,000 | 0.14% |
Ikarian Capital, LLC | 454,346 | $1,867,000 | 0.13% |
Orbimed Advisors | 2,711,600 | $11,145,000 | 0.12% |
AlphaCentric Advisors LLC | 114,000 | $469,000 | 0.12% |